WASF2
Basic information
Region (hg38): 1:27404230-27490167
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the WASF2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 24 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 3 | 0 |
Variants in WASF2
This is a list of pathogenic ClinVar variants found in the WASF2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-27408193-T-C | not specified | Uncertain significance (Jun 03, 2022) | ||
1-27408229-T-A | not specified | Uncertain significance (Apr 23, 2024) | ||
1-27408265-G-C | not specified | Uncertain significance (Feb 12, 2024) | ||
1-27408335-G-A | not specified | Uncertain significance (Oct 17, 2023) | ||
1-27409772-A-G | not specified | Uncertain significance (Jan 10, 2023) | ||
1-27409775-G-A | not specified | Uncertain significance (Jan 23, 2023) | ||
1-27409832-G-A | not specified | Uncertain significance (Oct 29, 2021) | ||
1-27409840-A-G | Likely benign (Mar 28, 2018) | |||
1-27409854-G-T | not specified | Uncertain significance (Mar 01, 2024) | ||
1-27409934-G-C | not specified | Uncertain significance (Jan 25, 2023) | ||
1-27410034-G-A | not specified | Uncertain significance (Apr 25, 2023) | ||
1-27410054-G-A | not specified | Uncertain significance (Mar 29, 2022) | ||
1-27410090-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
1-27410103-G-T | not specified | Uncertain significance (Feb 11, 2022) | ||
1-27412584-G-A | not specified | Uncertain significance (Nov 03, 2023) | ||
1-27412626-G-A | not specified | Uncertain significance (Aug 02, 2023) | ||
1-27412656-G-A | Likely benign (Apr 02, 2018) | |||
1-27412665-C-T | not specified | Uncertain significance (Apr 26, 2023) | ||
1-27412705-G-T | not specified | Uncertain significance (Jan 30, 2024) | ||
1-27414962-T-C | not specified | Uncertain significance (Jul 25, 2023) | ||
1-27416079-T-C | not specified | Uncertain significance (Oct 04, 2022) | ||
1-27418345-A-T | not specified | Uncertain significance (Apr 24, 2024) | ||
1-27418350-C-T | not specified | Uncertain significance (Mar 16, 2022) | ||
1-27418375-T-C | not specified | Uncertain significance (Jun 28, 2022) | ||
1-27418998-C-T | not specified | Uncertain significance (May 02, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
WASF2 | protein_coding | protein_coding | ENST00000430629 | 8 | 85940 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.976 | 0.0243 | 125741 | 0 | 7 | 125748 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.77 | 206 | 291 | 0.708 | 0.0000161 | 3220 |
Missense in Polyphen | 21 | 34.554 | 0.60775 | 301 | ||
Synonymous | 0.299 | 107 | 111 | 0.964 | 0.00000660 | 1058 |
Loss of Function | 3.76 | 2 | 20.2 | 0.0988 | 0.00000108 | 232 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000289 | 0.0000289 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000545 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000352 | 0.0000352 |
Middle Eastern | 0.0000545 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Downstream effector molecule involved in the transmission of signals from tyrosine kinase receptors and small GTPases to the actin cytoskeleton. Promotes formation of actin filaments. Part of the WAVE complex that regulates lamellipodia formation. The WAVE complex regulates actin filament reorganization via its interaction with the Arp2/3 complex. {ECO:0000269|PubMed:10381382, ECO:0000269|PubMed:16275905}.;
- Pathway
- Fc gamma R-mediated phagocytosis - Homo sapiens (human);Salmonella infection - Homo sapiens (human);Choline metabolism in cancer - Homo sapiens (human);Adherens junction - Homo sapiens (human);Regulation of actin cytoskeleton - Homo sapiens (human);Bacterial invasion of epithelial cells - Homo sapiens (human);Shigellosis - Homo sapiens (human);Regulation of Actin Cytoskeleton;Signal Transduction;VEGFA-VEGFR2 Pathway;y branching of actin filaments;Fcgamma receptor (FCGR) dependent phagocytosis;Innate Immune System;Immune System;RHO GTPases Activate WASPs and WAVEs;RHO GTPase Effectors;Signaling by Rho GTPases;ErbB1 downstream signaling;Regulation of actin dynamics for phagocytic cup formation;Signaling by VEGF;Signaling by Receptor Tyrosine Kinases;RAC1 signaling pathway;PDGFR-beta signaling pathway;E-cadherin signaling in the nascent adherens junction
(Consensus)
Recessive Scores
- pRec
- 0.181
Intolerance Scores
- loftool
- 0.309
- rvis_EVS
- 0
- rvis_percentile_EVS
- 53.73
Haploinsufficiency Scores
- pHI
- 0.442
- hipred
- Y
- hipred_score
- 0.628
- ghis
- 0.493
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.674
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Wasf2
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; muscle phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- angiogenesis;ameboidal-type cell migration;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;positive regulation of lamellipodium assembly;viral process;Rac protein signal transduction;lamellipodium assembly;actin cytoskeleton organization;actin filament-based movement;megakaryocyte development;Fc-gamma receptor signaling pathway involved in phagocytosis;vascular endothelial growth factor receptor signaling pathway;negative regulation of stress fiber assembly;lamellipodium morphogenesis;postsynaptic actin cytoskeleton organization
- Cellular component
- ruffle;early endosome;cytosol;cell-cell junction;actin cytoskeleton;lamellipodium;SCAR complex;protein-containing complex;synapse;extracellular exosome
- Molecular function
- actin binding;protein binding;SH3 domain binding;cadherin binding;protein kinase A binding